RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Linda Spatz to DNA

This is a "connection" page, showing publications Linda Spatz has written about DNA.
Connection Strength

2.019
DNA
  1. Singh D, Oudit O, Hajtovic S, Sarbaugh D, Salis R, Adebowale T, James J, Spatz LA. Antibodies to an Epstein Barr Virus protein that cross-react with dsDNA have pathogenic potential. Mol Immunol. 2021 04; 132:41-52.
    View in: PubMed
    Score: 0.632
  2. Yadav P, Tran H, Ebegbe R, Gottlieb P, Wei H, Lewis RH, Mumbey-Wafula A, Kaplan A, Kholdarova E, Spatz L. Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One. 2011 Jan 04; 6(1):e14488.
    View in: PubMed
    Score: 0.314
  3. Thorn M, Lewis RH, Mumbey-Wafula A, Kantrowitz S, Spatz LA. BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion. Cell Immunol. 2010; 261(1):9-22.
    View in: PubMed
    Score: 0.289
  4. Taylor DK, Ito E, Thorn M, Sundar K, Tedder T, Spatz LA. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19. Mol Immunol. 2006 Apr; 43(11):1776-90.
    View in: PubMed
    Score: 0.223
  5. Chu YP, Taylor D, Yan HG, Diamond B, Spatz L. Persistence of partially functional double-stranded (ds) DNA binding B cells in mice transgenic for the IgM heavy chain of an anti-dsDNA antibody. Int Immunol. 2002 Jan; 14(1):45-54.
    View in: PubMed
    Score: 0.168
  6. Spatz L, Saenko V, Iliev A, Jones L, Geskin L, Diamond B. Light chain usage in anti-double-stranded DNA B cell subsets: role in cell fate determination. J Exp Med. 1997 Apr 07; 185(7):1317-26.
    View in: PubMed
    Score: 0.121
  7. Spatz L, Iliev A, Saenko V, Jones L, Irigoyen M, Manheimer-Lory A, Gaynor B, Putterman C, Bynoe M, Kowal C, Kuo P, Newman J, Diamond B. Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies. Methods. 1997 Jan; 11(1):70-8.
    View in: PubMed
    Score: 0.119
  8. Spatz LA, Williams M, Brender B, Desai R, Latov N. DNA sequence analysis and comparison of the variable heavy and light chain regions of two IgM, monoclonal, anti-myelin associated glycoprotein antibodies. J Neuroimmunol. 1992 Jan; 36(1):29-39.
    View in: PubMed
    Score: 0.084
  9. Bynoe MS, Spatz L, Diamond B. Characterization of anti-DNA B cells that escape negative selection. Eur J Immunol. 1999 04; 29(4):1304-13.
    View in: PubMed
    Score: 0.035
  10. Spatz LA, Daugherty BL, DeMartino JA, Mark GE, Latov N. Expression of recombinant human anti-MAG antibodies in non-lymphoid mammalian cells. Hum Antibodies Hybridomas. 1992 Apr; 3(2):107-11.
    View in: PubMed
    Score: 0.021
  11. Gaynor B, Putterman C, Valadon P, Spatz L, Scharff MD, Diamond B. Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A. 1997 Mar 04; 94(5):1955-60.
    View in: PubMed
    Score: 0.008
  12. Desai R, Spatz L, Matsuda T, Ilyas AA, Berman JE, Alt FW, Kabat EA, Latov N. Molecular cloning of a human immunoglobulin heavy chain variable (VH) region with anti-myelin-associated glycoprotein activity. J Neuroimmunol. 1990 Jan; 26(1):35-41.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support